Discovery of novel pyruvate dehydrogenase kinase 4 inhibitors for potential oral treatment of metabolic diseases

D Lee, HS Pagire, SH Pagire, EJ Bae… - Journal of Medicinal …, 2019 - ACS Publications
Pyruvate dehydrogenase kinase 4 (PDK4) activation is associated with metabolic diseases
including hyperglycemia, insulin resistance, allergies, and cancer. Structural modifications of …
被引用次数：24 相关文章

Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases

D Lee, HS Pagire, SH Pagire… - Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Pyruvate dehydrogenase kinase 4 (PDK4) activation is associated with metabolic diseases
including hyperglycemia, insulin resistance, allergies, and cancer. Structural modifications of …

Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases

D Lee, HS Pagire, SH Pagire, EJ Bae… - Journal of Medicinal …, 2019 - research.knu.ac.kr
Abstract Pyruvate dehydrogenase kinase 4 (PDK4) activation is associated with metabolic
diseases including hyperglycemia, insulin resistance, allergies, and cancer. Structural …

Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.

D Lee, HS Pagire, SH Pagire, EJ Bae… - Journal of Medicinal …, 2019 - europepmc.org
Pyruvate dehydrogenase kinase 4 (PDK4) activation is associated with metabolic diseases
including hyperglycemia, insulin resistance, allergies, and cancer. Structural modifications of …